Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1963 1
1968 1
1976 1
1982 1
1988 3
1989 1
1990 1
1993 1
1994 2
1995 3
1996 3
1997 1
1999 4
2000 5
2001 3
2002 2
2003 2
2004 4
2005 1
2006 1
2007 5
2008 7
2009 9
2010 5
2011 5
2012 5
2013 6
2014 12
2015 8
2016 7
2017 6
2018 12
2019 6
2020 6
2021 4
2022 3
2023 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Immediate hypersensitivity to p-phenylenediamine.
Wilkinson M, Solman L, Coenraads PJ, Goebel C. Wilkinson M, et al. Among authors: goebel c. Contact Dermatitis. 2019 Mar;80(3):177-178. doi: 10.1111/cod.13156. Epub 2018 Nov 13. Contact Dermatitis. 2019. PMID: 30426523 No abstract available.
Extrahepatic metabolism at the body's internal-external interfaces.
Gundert-Remy U, Bernauer U, Blömeke B, Döring B, Fabian E, Goebel C, Hessel S, Jäckh C, Lampen A, Oesch F, Petzinger E, Völkel W, Roos PH. Gundert-Remy U, et al. Among authors: goebel c. Drug Metab Rev. 2014 Aug;46(3):291-324. doi: 10.3109/03602532.2014.900565. Epub 2014 Mar 25. Drug Metab Rev. 2014. PMID: 24666398 Review.
Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype.
Goodman AD, Fedler JK, Yankey J, Klingner EA, Ecklund DJ, Goebel CV, Bermel RA, Chase M, Coffey CS, Klawiter EC, Naismith RT, Fox RJ; SPRINT-MS Investigators. Goodman AD, et al. Among authors: goebel cv. Ann Clin Transl Neurol. 2021 Jan;8(1):111-118. doi: 10.1002/acn3.51251. Epub 2021 Jan 18. Ann Clin Transl Neurol. 2021. PMID: 33460301 Free PMC article. Clinical Trial.
Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study.
Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ; SPRINT-MS investigators. Naismith RT, et al. Among authors: goebel c. Neurology. 2021 Jan 26;96(4):e491-e500. doi: 10.1212/WNL.0000000000011314. Epub 2020 Dec 2. Neurology. 2021. PMID: 33268562 Free PMC article. Clinical Trial.
Stimulating luteinizing hormone.
Goebel C. Goebel C. Drug Test Anal. 2011 Nov-Dec;3(11-12):868-72. doi: 10.1002/dta.393. Epub 2011 Dec 6. Drug Test Anal. 2011. PMID: 22147514
Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database<sup/>
Hoffmann S, Kleinstreuer N, Alépée N, Allen D, Api AM, Ashikaga T, Clouet E, Cluzel M, Desprez B, Gellatly N, Goebel C, Kern PS, Klaric M, Kühnl J, Lalko JF, Martinozzi-Teissier S, Mewes K, Miyazawa M, Parakhia R, van Vliet E, Zang Q, Petersohn D. Hoffmann S, et al. Among authors: goebel c. Crit Rev Toxicol. 2018 May;48(5):344-358. doi: 10.1080/10408444.2018.1429385. Epub 2018 Feb 23. Crit Rev Toxicol. 2018. PMID: 29474128 Review.
Categorization of chemicals according to their relative human skin sensitizing potency.
Basketter DA, Alépée N, Ashikaga T, Barroso J, Gilmour N, Goebel C, Hibatallah J, Hoffmann S, Kern P, Martinozzi-Teissier S, Maxwell G, Reisinger K, Sakaguchi H, Schepky A, Tailhardat M, Templier M. Basketter DA, et al. Among authors: goebel c. Dermatitis. 2014 Jan-Feb;25(1):11-21. doi: 10.1097/DER.0000000000000003. Dermatitis. 2014. PMID: 24407057 Review.
140 results